Similares a What Comes Next for PORT-77 as It Heads Toward Phase 2b/3?

20 vecinos (text_768) · 196 views · HCPLive · Estados Unidos


★	What Comes Next for PORT-77 as It Heads Toward Phase 2b/3?	HCPLive @hcplivenews	196	Estados Unidos
12	Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata	HCPLive @hcplivenews	611	Estados Unidos	85
15	Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B	HCPLive @hcplivenews	521	Estados Unidos	85
6	GP-SOD Plus Targeted Phototherapy Improves Vitiligo Repigmentation	HCPLive @hcplivenews	249	Estados Unidos	85
5	Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing	HCPLive @hcplivenews	209	Estados Unidos	85
20	GDF2026 - Q&A Discussion Panel Four and Day One Closing	U.S. Food and Drug Administration @us_fda	187	Estados Unidos	85
11	Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD	HCPLive @hcplivenews	172	Estados Unidos	85
9	Vitiligo Pipeline Update: George Martin, MD, on JAK Inhibitors & Melasma Treatment	HCPLive @hcplivenews	143	Estados Unidos	85
14	GDF2026 - Q&A Discussion Panel Two	U.S. Food and Drug Administration @us_fda	136	Estados Unidos	85
13	Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD	HCPLive @hcplivenews	102	Estados Unidos	85
17	How Upadacitinib Could Expand Options for Severe Alopecia Areata, With Natasha Mesinkovska, MD, PhD	HCPLive @hcplivenews	93	Estados Unidos	85
3	What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis?	HCPLive @hcplivenews	91	Estados Unidos	86
7	Robert Wood, MD, on Age, Dosing in Multifood Allergy OIT	HCPLive @hcplivenews	70	Estados Unidos	85
19	GDF2026 - FDA Commissioner Keynote	U.S. Food and Drug Administration @us_fda	66	Estados Unidos	85
4	GP-SOD Plus Targeted Phototherapy for Vitiligo: Safety, Dosing, Next Steps	HCPLive @hcplivenews	60	Estados Unidos	86
8	Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA	HCPLive @hcplivenews	30	Estados Unidos	85
2	Cheval de Troie nanoscopique pour infiltrer et saboter la forteresse cancéreuse par Valentin Lecomte	MUMONS @mumons	27	Bélgica	86
18	Biphasic Dose Response in Low Level Light Therapy \| RTCL.TV	Medicine RTCL TV @medicinertcltv	21	Estados Unidos	85
10	HCPLive Five: Maui Derm NP+PA Summer 2026	HCPLive @hcplivenews	20	Estados Unidos	85
1	How ABCG2 Inhibition Could Change EPP Disease Management	HCPLive @hcplivenews	17	Estados Unidos	93
16	Falling in & out of love with pharma at Next Pharma Summit	Brandcast Health @brandcasthealthuk	16	—	85